Condensed Consolidated Statements of Operations and Comprehensive loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Revenues		$ 56,604	$ 65,160	$ 161,582
Operating Expenses:
Research and development expenses	205,659	37	219,764	29,459
Selling and marketing expenses	255,853		287,317	22,411
General and administrative expenses	530,877	102,265	826,861	502,091
Operating loss	992,389	45,698	1,268,782	392,379
Financing expenses (income), net	20,082	(20,282)	35,645	59,488
Net loss	$ 1,012,471	$ 25,416	$ 1,304,427	$ 451,867
Loss per share (basic and diluted) (in Dollars per share)	$ (0.03)	$ 0	$ (0.03)	$ (0.01)
Basic and diluted weighted average number of shares of common stock outstanding (1) (in Shares)	39,232,570	39,232,570	39,232,570	39,232,570